19 May 2013
Keywords: ligand, narrows, loss, rocketing, revenue, pharmaceuticals, narrowed
Article | 08 May 2009
Ligand Pharmaceuticals narrowed its loss by 23% year-on-year for the first quarter, on rocketing revenue driven by royalties and the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 May 2009
7 May 2009
17 May 2013
© 2013 thepharmaletter.com